These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24586482)

  • 1. rtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virus.
    Liu Y; Xu Z; Wang Y; Li X; Liu L; Chen L; Xin S; Xu D
    PLoS One; 2014; 9(2):e89015. PubMed ID: 24586482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
    Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
    Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil.
    Liu Y; Li X; Xin S; Xu Z; Chen R; Yang J; Liu L; Wong VW; Yang D; Chan HL; Xu D
    J Viral Hepat; 2015 Mar; 22(3):328-34. PubMed ID: 25132017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients.
    Liu Y; Liu W; Li X; Xu Z; Wang X; Li C; Chen L; Xin S; Xu D
    Antivir Ther; 2014; 19(6):551-8. PubMed ID: 24710668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility.
    Fan J; Wang Y; Xiong H; Guo X; Cheng YC
    J Gen Virol; 2014 Nov; 95(Pt 11):2523-2530. PubMed ID: 25028473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B.
    Zhong Y; Lv J; Li J; Xing X; Zhu H; Su H; Chen L; Zhou X
    Antiviral Res; 2012 Jan; 93(1):185-90. PubMed ID: 22138714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues.
    Wang F; Wang H; Shen H; Meng C; Weng X; Zhang W
    Clin Ther; 2009 Feb; 31(2):360-6. PubMed ID: 19302908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome.
    Amini-Bavil-Olyaee S; Herbers U; Mohebbi SR; Sabahi F; Zali MR; Luedde T; Trautwein C; Tacke F
    J Hepatol; 2009 Oct; 51(4):647-54. PubMed ID: 19586679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial virological response and viral mutation with adefovir dipivoxil added to ongoing Lamivudine therapy in Lamivudine-resistant chronic hepatitis B.
    Wu S; Fukai K; Imazeki F; Arai M; Kanda T; Yonemitsu Y; Yokosuka O
    Dig Dis Sci; 2011 Apr; 56(4):1207-14. PubMed ID: 20927588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased occurrence of mutant rtI233V of HBV in patients receiving adefovir therapy.
    Liu Y; Xin S; Ye X; Chen R; Xu Z; Li X; Ye H; Cheng S; Xu D
    Antivir Ther; 2016; 21(1):9-16. PubMed ID: 26079809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of therapy in patients with chronic hepatitis B virus.
    Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
    Ji D; Liu Y; Li L; Xu Z; Si LL; Dai JZ; Li X; Wang L; Yao Z; Xin SJ; Chen GF; Xu D
    J Clin Virol; 2012 May; 54(1):66-72. PubMed ID: 22398037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
    Zhu Y; Curtis M; Borroto-Esoda K
    Antivir Chem Chemother; 2011 Aug; 22(1):13-22. PubMed ID: 21860069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
    Dai CY; Chuang WL; Hsieh MY; Lee LP; Huang JF; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
    Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.
    Chen CH; Lee CM; Tung WC; Wang JH; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS
    J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient.
    Zhang Q; Chen J; Pan M; Liu J; Liu T; Zhou YH
    Virus Res; 2018 Aug; 255():165-170. PubMed ID: 30075160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].
    Liang PP; Guo JJ; Li QL; Luo Q; Shi XF; Huang AL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):516-20. PubMed ID: 22152243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
    Kim SS; Cho SW; Kim SO; Hong SP; Cheong JY
    J Med Virol; 2013 Jan; 85(1):55-64. PubMed ID: 23096938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.
    Liu Y; Wang C; Zhong Y; Li X; Dai J; Ren X; Xu Z; Li L; Yao Z; Ji D; Wang L; Zhang L; Wong VW; Zoulim F; Xu D
    J Viral Hepat; 2011 Apr; 18(4):e29-39. PubMed ID: 21392168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.